Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-20 · accession 0001104659-26-005440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | 2026-01-20 | PTGX | Ali Asif | CFO | S - Sale | $82.48 | -8,588 | 78.1K | -10% | -$708.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | S | D | 8,588 | $82.48 | 78,077 | D | — | — | (F1) Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. |